Disease | mccune-albright syndrome |
Comorbidity | C0034013|precocious puberty |
Sentences | 3 |
PubMedID- 22051789 | Summary and conclusion: although different in presentation, all three atypical cases of suspected mccune-albright syndrome with gonadotropin-independent precocious puberty were successfully treated with aromatase inhibitors. |
PubMedID- 22068112 | Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to mccune-albright syndrome. |
PubMedID- 22999294 | The objective of this study was to evaluate the safety and efficacy of fulvestrant (faslodextm), a pure estrogen receptor antagonist, in girls with progressive precocious puberty (pp) associated with mccune-albright syndrome (mas). |
Page: 1